HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 289/5/G815    most recent 00001.2005v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (7) Citing Articles via Google Scholar Google Scholar Articles by Grishin, A. Articles by Zaks-Makhina, E. Search for Related Content PubMed PubMed Citation Articles by Grishin, A. Articles by Zaks-Makhina, E.

MUCOSAL BIOLOGY

Attenuation of apoptosis in enterocytes by blockade of potassium channels

¹Division of Pediatric Surgery, Children’s Hospital of Los Angeles, Los Angeles, California; and ²Department of Pharmacology, University of Pittsburgh Medical School, Pittsburgh, Pennsylvania

Submitted 4 January 2005 ; accepted in final form 29 June 2005

Apoptosis plays an important role in maintaining the balance between proliferation and cell loss in the intestinal epithelium. Apoptosis rates may increase in intestinal pathologies such as inflammatory bowel disease and necrotizing enterocolitis, suggesting pharmacological prevention of apoptosis as a therapy for these conditions. Here, we explore the feasibility of this approach using the rat epithelial cell line IEC-6 as a model. On the basis of the known role of K⁺ efflux in apoptosis in various cell types, we hypothesized that K⁺ efflux is essential for apoptosis in enterocytes and that pharmacological blockade of this efflux would inhibit apoptosis. By probing intracellular [K⁺] with the K⁺-sensitive fluorescent dye and measuring the efflux of ⁸⁶Rb⁺, we found that apoptosis-inducing treatment with the proteasome inhibitor MG-132 leads to a twofold increase in K⁺ efflux from IEC-6 cells. Blockade of K⁺ efflux with tetraethylammonium, 4-aminopyridine, stromatoxin, chromanol 293B, and the recently described K⁺ channel inhibitor 48F10 prevents DNA fragmentation, caspase activation, release of cytochrome c from mitochondria, and loss of mitochondrial membrane potential. Thus K⁺ efflux occurs early in the apoptotic program and is required for the execution of later events. Apoptotic K⁺ efflux critically depends on activation of p38 MAPK. These results demonstrate for the first time the requirement of K⁺ channel-mediated K⁺ efflux for progression of apoptosis in enterocytes and suggest the use of K⁺ channel blockers to prevent apoptotic cell loss occurring in intestinal pathologies.

IEC-6 cells; apoptotic K⁺ efflux; p38 mitogen-activated protein kinase; intestinal pathologies

This article has been cited by other articles:

				M. T. Andres, M. Viejo-Diaz, and J. F. Fierro Human Lactoferrin Induces Apoptosis-Like Cell Death in Candida albicans: Critical Role of K+-Channel-Mediated K+ Efflux Antimicrob. Agents Chemother., November 1, 2008; 52(11): 4081 - 4088. [Abstract] [Full Text] [PDF]

				D. Heitzmann and R. Warth Physiology and Pathophysiology of Potassium Channels in Gastrointestinal Epithelia Physiol Rev, July 1, 2008; 88(3): 1119 - 1182. [Abstract] [Full Text] [PDF]